Overview

Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism

Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
Evaluation of efficacy and safety of testosterone enanthate administered subcutaneously using an auto-injector
Phase:
Phase 3
Details
Lead Sponsor:
Antares Pharma Inc.
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate